share_log

Aclarion | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-White Lion Capital, LLC(0.0%)

SEC announcement ·  Mar 29 17:04
Summary by Moomoo AI
White Lion Capital, LLC, an investment firm based in Nevada, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 31, 2024, indicating that they no longer hold any shares in Aclarion, Inc. This amendment reflects that White Lion Capital has ceased to be the beneficial owner of more than 5% of Aclarion's common stock, which has a par value of $0.00001 per share and a CUSIP number of 655187201. The filing was made in accordance with the Securities Act of 1934, and the percentage ownership was calculated based on 1,975,585 shares of common stock outstanding as of February 26, 2024, as reported by Aclarion, Inc. The address of Aclarion's principal executive offices is listed as 8181 Arista Place, Suite 100, Broomfield, CO 80021. White Lion Capital has confirmed that the disposition of the shares is not related to any intent to change or influence the control of Aclarion, Inc.
White Lion Capital, LLC, an investment firm based in Nevada, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 31, 2024, indicating that they no longer hold any shares in Aclarion, Inc. This amendment reflects that White Lion Capital has ceased to be the beneficial owner of more than 5% of Aclarion's common stock, which has a par value of $0.00001 per share and a CUSIP number of 655187201. The filing was made in accordance with the Securities Act of 1934, and the percentage ownership was calculated based on 1,975,585 shares of common stock outstanding as of February 26, 2024, as reported by Aclarion, Inc. The address of Aclarion's principal executive offices is listed as 8181 Arista Place, Suite 100, Broomfield, CO 80021. White Lion Capital has confirmed that the disposition of the shares is not related to any intent to change or influence the control of Aclarion, Inc.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more